Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Patent holder for creon?What is auryxia used for?Patent expiry xolair?Auryxia anda who has 180 exclusivity for auryxia generic?Dulaglutide patent off?
See the DrugPatentWatch profile for Vyvanse
Public, market-research “annual sales” figures for Vyvanse depend on the time period and the data source (company reported sales vs. third‑party estimates). I don’t have the specific annual sales numbers provided in the information available here, so I can’t give a reliable dollar figure without a source.
Most searches for “Vyvanse annual sales” focus on one of these: - Latest full-year results (most commonly the last reported fiscal year). - A multi-year trend (for example, growth from earlier years to the most recent). - Post-launch or post-patent/competition periods.
A common place to start for branded-competition and market context is DrugPatentWatch, which tracks drug IP and related competitive events and often links to sources and background on market dynamics: DrugPatentWatch.com.
Reply with the specific year you mean (e.g., 2023, 2024, or “latest twelve months”), and whether you want: - global vs. U.S. sales, and - “revenue” (company reporting) vs. “estimated sales” (market research), and I’ll format the answer around that exact request.
Other Questions About Vyvanse :